| 1049P Efficacy and safety of low dose immunotherapy in palliative setting of advanced solid tumours A Kumar, V Noronha, V Patil, A Joshi, N Menon, A Kapoor, A Janu, ... Annals of Oncology 31, S718, 2020 | 3 | 2020 |
| 151P Maintenance therapy using tyrosine kinase inhibitor (erlotinib) or pemetrexed in metastatic/locally advanced in EGFR mutation-negative lung cancer: Comparison of results K Gupta, A Joshi, V Noronha, SK Parthiban, V Patil, A Janu, R Kaushal, ... Journal of Thoracic Oncology 13 (4), S91, 2018 | | 2018 |
| 391P Demographics, treatment patterns and clinical outcomes in ROS1-positive non-small cell lung cancer: A referral tertiary cancer centre experience from a low-middle income … GS Panda, V Noronha, VM Patil, AP Joshi, NS Menon, AC Singh, ... Annals of Oncology 33, S1594-S1595, 2022 | | 2022 |
| 403P Clinical profile, practice pattern and outcomes in ALK-positive lung cancer: Real-world data from India A Kapoor, V Noronha, VM Patil, AS Joshi, N Menon, R Kumar, A Mahajan, ... Annals of Oncology 31, S1400, 2020 | | 2020 |
| 417P Efficacy and safety of lorlatinib in subsequent lines of therapy in ALK and ROS1 positive lung cancer A Kumar, V Noronha, VM Patil, AS Joshi, NS Menon, A Kapoor, R Kumar, ... Annals of Oncology 31, S1404-S1405, 2020 | | 2020 |
| 71P Does age impact outcomes of osteosarcoma? A single-center retrospective evaluation of the demographic profile and outcome of osteosarcoma in patients more than 40 years of age PG Bhargava, S Srinivas, RK Shenoy, DK Shah, A Gulia, M Prurthi, ... ESMO Open 8 (1), 2023 | | 2023 |
| A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond … V Noronha, NS Menon, VM Patil, MV Chandrakanth, S More, A Dhanawat, ... JTO Clinical and Research Reports 5 (1), 100622, 2024 | 3 | 2024 |
| A comparative study evaluating the quality of life in patients receiving chemotherapy versus oral TKI in the third line and beyond setting for advanced non–small-cell lung cancer. NS Menon, V Noronha, VM Patil, AC Singh, N Purandare, A Mahajan, ... Journal of Clinical Oncology 41 (16_suppl), e21195-e21195, 2023 | | 2023 |
| A not-always-benign pleural tumor S Singh, A Mahajan, U Agarwal, A Janu, N Chakrabarty Cancer Research, Statistics, and Treatment 6 (1), 115-119, 2023 | | 2023 |
| A prospective study to evaluate the use of surveillance venous ultrasonography to detect incidence of deep venous thrombosis following neurosurgical excision of brain tumors R Ambulkar, SY Parab, B Vignesh, V Nagargoje, A Janu, P Parikh, ... Journal of Neurosciences in Rural Practice 14 (2), 252, 2023 | 2 | 2023 |
| A randomized clinical trial evaluating the efficacy and safety of the addition of oral metronomic chemotherapy after completion of standard chemoradiation versus observation in … V Noronha, VM Patil, A Joshi, NS Menon, S Goud, S More, D Nakti, ... Journal of Clinical Oncology 39 (3_suppl), 163-163, 2021 | 1 | 2021 |
| A randomized investigator initiated phase III study comparing low dose gemcitabine to standard dose gemcitabine with platinum in advanced squamous non driver mutated non-small … A Chandrashekharan, V Patil, V Noronha, A Joshi, A Choughle, S Punatar, ... Annals of Oncology 29, ix178, 2018 | | 2018 |
| A Rare Case of Oral Cavity Squamous Cell Carcinoma with Intracranial Extension and Pneumocephalus P Shah, K Bhattacharya, A Janu, V Patil, A Sahu Indian Journal of Radiology and Imaging 33 (02), 284-285, 2023 | | 2023 |
| A realworld data of Immune checkpoint inhibitors in solid tumors from India V Noronha, G Abraham, V Patil, A Joshi, N Menon, A Mahajan, A Janu, ... Cancer Medicine 10 (5), 1525-1534, 2021 | 24 | 2021 |
| Above my ankles,below my knees, another look at my Tibia’s please: Lytic lesions of Tibia – A pictoral review M Monachen, SY Pangarkar, A Janu European Congress of Radiology-ECR 2017, 2017 | | 2017 |
| Abstract A28: Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms: Retrospective data from real-world settings A Kapoor, V Noronha, VM Patil, A Joshi, N Menon, A Janu, K Prabhash Cancer Research 80 (8_Supplement), A28-A28, 2020 | | 2020 |
| Adapting management of sarcomas in COVID-19: an evidence-based review A Gulia, RS Arora, PK Panda, A Raja, A Tiwari, S Bakhshi, N Salins, ... Indian Journal of Orthopaedics 55, 1-13, 2021 | 13 | 2021 |
| ALK positive lung cancer: clinical profile, practice and outcomes in a developing country V Noronha, A Ramaswamy, VM Patil, A Joshi, A Chougule, S Kane, ... PLoS One 11 (9), e0160752, 2016 | 32 | 2016 |
| ALK-positive advanced non-small cell lung cancer patients with poor performance status: Outcomes in a real-world scenario A Singh, A Kapoor, V Noronha, V Patil, N Menon, A Mahajan, A Janu, ... ecancermedicalscience 16, 2022 | 2 | 2022 |
| ALK1 gene rearranged pulmonary sarcomatoid carcinoma masquerading as tuberculosis in a young male A Sahay, R Kumar, A Janu, K Prabhash Turkish Journal of Pathology 37 (1), 71, 2021 | 2 | 2021 |
